191 related articles for article (PubMed ID: 37296459)
1. "We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
Claborn K; Samora J; McCormick K; Whittfield Q; Courtois F; Lozada K; Sledge D; Burwell A; Chavez S; Bailey J; Bailey C; Pederson CD; Zagorski C; Hill L; Conway FN; Steiker LH; Cance J; Potter J
Harm Reduct J; 2023 Jun; 20(1):70. PubMed ID: 37296459
[TBL] [Abstract][Full Text] [Related]
2. "If It Didn't Get Reported, It Didn't Happen": Current Nonfatal Overdose Reporting Practices among Nontraditional Reporters in Texas.
Claborn K; Cance JD; Kane H; Hairgrove S; Conway FN
Subst Use Misuse; 2023; 58(6):828-831. PubMed ID: 36943062
[No Abstract] [Full Text] [Related]
3. Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study.
Safi F; Rioux W; Rider N; Fornssler B; Jones S; Ghosh SM
Harm Reduct J; 2023 May; 20(1):64. PubMed ID: 37158926
[TBL] [Abstract][Full Text] [Related]
4. Ethical by Design: Engaging the Community to Co-design a Digital Health Ecosystem to Improve Overdose Prevention Efforts Among Highly Vulnerable People Who Use Drugs.
Claborn KR; Creech S; Whittfield Q; Parra-Cardona R; Daugherty A; Benzer J
Front Digit Health; 2022; 4():880849. PubMed ID: 35712228
[TBL] [Abstract][Full Text] [Related]
5. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
[TBL] [Abstract][Full Text] [Related]
6. Perspectives of healthcare workers on the integration of overdose detection technologies in acute care settings.
Rioux W; Kilby K; Jones S; Joshi P; Vandenberg S; Ghosh SM
Addict Sci Clin Pract; 2024 Jan; 19(1):4. PubMed ID: 38217056
[TBL] [Abstract][Full Text] [Related]
7. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.
Perri M; Kaminski N; Bonn M; Kolla G; Guta A; Bayoumi AM; Challacombe L; Gagnon M; Touesnard N; McDougall P; Strike C
Harm Reduct J; 2021 Aug; 18(1):85. PubMed ID: 34353323
[TBL] [Abstract][Full Text] [Related]
8. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
Moran L; Ondocsin J; Outram S; Ciccarone D; Werb D; Holm N; Arnold EA
Harm Reduct J; 2024 May; 21(1):92. PubMed ID: 38734643
[TBL] [Abstract][Full Text] [Related]
9. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities.
Ezell JM; Walters S; Friedman SR; Bolinski R; Jenkins WD; Schneider J; Link B; Pho MT
Soc Sci Med; 2021 Jan; 268():113470. PubMed ID: 33253992
[TBL] [Abstract][Full Text] [Related]
10. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
[TBL] [Abstract][Full Text] [Related]
11. Development of a digital platform to improve community response to overdose and prevention among harm reduction organizations.
Claborn K; Creech S; Conway FN; Clinton NM; Brinkley KT; Lippard E; Ramos T; Samora J; Miri A; Benzer J
Harm Reduct J; 2022 Jun; 19(1):62. PubMed ID: 35658871
[TBL] [Abstract][Full Text] [Related]
12. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
13. Practices of care among people who buy, use, and sell drugs in community settings.
Kolla G; Strike C
Harm Reduct J; 2020 May; 17(1):27. PubMed ID: 32381011
[TBL] [Abstract][Full Text] [Related]
14. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
[TBL] [Abstract][Full Text] [Related]
15. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL; Macmadu A
Harm Reduct J; 2023 Feb; 20(1):14. PubMed ID: 36739417
[TBL] [Abstract][Full Text] [Related]
16. "It's an emotional roller coaster… But sometimes it's fucking awesome": Meaning and motivation of work for peers in overdose response environments in British Columbia.
Pauly BB; Mamdani Z; Mesley L; McKenzie S; Cameron F; Edwards D; Howell A; Knott M; Scott T; Seguin R; Greer AM; Buxton JA
Int J Drug Policy; 2021 Feb; 88():103015. PubMed ID: 33176249
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.
Conway FN; Samora J; Brinkley K; Jeong H; Clinton N; Claborn KR
Harm Reduct J; 2022 Jul; 19(1):72. PubMed ID: 35780109
[TBL] [Abstract][Full Text] [Related]
18. How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective.
Jiao S; Bungay V; Jenkins E; Gagnon M
Harm Reduct J; 2023 Sep; 20(1):139. PubMed ID: 37735432
[TBL] [Abstract][Full Text] [Related]
19. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
[TBL] [Abstract][Full Text] [Related]
20. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
Reed MK; Salcedo VJ; Guth A; Rising KL
J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
